Home/Filings/4/0001225208-16-027764
4//SEC Filing

Merck & Co., Inc. 4

Accession 0001225208-16-027764

$MRKCIK 0000310158operating

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 12:38 PM ET

Size

4.8 KB

Accession

0001225208-16-027764

Insider Transaction Report

Form 4
Period: 2016-02-22
Rosenblatt Michael
Exec V-P & Chief Med Officer
Transactions
  • Award

    Common Stock

    2016-02-22$50.77/sh+7,738$392,85841,133.076 total
Footnotes (2)
  • [F1]Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards.
  • [F2]Holdings include shares acquired in dividend reinvestment transactions.

Documents

1 file

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0000310158

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 12:38 PM ET
Size
4.8 KB